PMSA
ABBV icon

Patrick M. Sweeney & Associates’s AbbVie ABBV Stock Holding History

Patrick M. Sweeney & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.69M Buy
26,600
+65
+0.2% +$14K 3.84% 4
2026
Q1 		$5.77M Buy
26,535
+25
+0.1% +$5.55K 3.7% 6
2025
Q4 		$6.06M Sell
26,510
-5
-0% -$1.14K 3.79% 5
2025
Q3 		$6.14M Buy
26,515
+30
+0.1% +$6.11K 3.97% 5
2025
Q2 		$5.01M Buy
26,485
+1
+0% +$186 3.45% 6
2025
Q1 		$5.55M Buy
26,484
+1
+0% +$194 4.15% 4
2024
Q4 		$4.71M Buy
26,483
+2
+0% +$368 3.53% 6
2024
Q3 		$5.23M Buy
26,481
+1
+0% +$187 3.84% 4
2024
Q2 		$4.54M Buy
26,480
+101
+0.4% +$16.7K 3.67% 7
2024
Q1 		$4.8M Buy
26,379
+2
+0% +$345 3.95% 7
2023
Q4 		$4.09M Buy
+26,377
New +$3.85M 3.74% 6

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Patrick M. Sweeney & Associates's ABBV Position: Q2 2026 in Review

Patrick M. Sweeney & Associates increased its AbbVie (ABBV) stake by 0.24% in Q2 2026, buying an estimated $14K and bringing the position to 26,600 shares worth $6.69M. The position accounts for 3.84% of the portfolio, ranked #4.

Patrick M. Sweeney & Associates first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Patrick M. Sweeney & Associates held 26,600 shares of AbbVie worth $6.69M as of Q2 2026.
  • Patrick M. Sweeney & Associates bought 65 AbbVie shares in Q2 2026, an estimated $14K.
  • AbbVie made up 3.84% of Patrick M. Sweeney & Associates's portfolio in Q2 2026, its #4 holding.
  • Patrick M. Sweeney & Associates first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Patrick M. Sweeney & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.